Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Exclusive News The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Author: Chris Markoch. First Published: 1/18/2026. 
Summary - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Investors typically target companies with disruptive technologies, exposure to an emerging trend, or a compelling turnaround narrative. Many of these firms will never survive or scale, but if one does, returns can be substantial. For investors who value crowd interest, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks. This ranking is based on the number of MarketBeat subscribers following each company. While popularity isn't a guarantee of success, it can provide added conviction. Wall Street veteran reveals #1 investment trend of 2026 (not AI)
Will you potentially make money or lose money in the U.S. stock market in 2026? According to the 50-year Wall Street legend who invented one of Wall Street's most popular buying and selling indicators – the answer has nothing to do with AI, quantum computing, or cryptos. Instead, it all comes down to the #1 stock he recommends you BUY now… And the #1 stock he recommends you SELL now. Some investors define penny stocks as any shares trading at $5 or less. The screener used here follows the traditional definition—stocks priced below $1. These securities are highly volatile, so conduct your own research and understand your risk tolerance before taking a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform is designed to simplify distribution and improve global accessibility. The bullish case for Vaxart centers on that innovative delivery approach. If the company secures FDA approval and successfully scales manufacturing and distribution, its oral vaccines could reduce logistical barriers for mass immunization campaigns and create licensing opportunities. Positive trial results or a commercial collaboration could also sharply change sentiment and valuation given the stock's current low base. Clinical risk remains the biggest challenge. Vaxart has not yet commercialized a product, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also limits visibility. For now, Vaxart is more of a long-term, speculative bet on platform validation than a near-term play on profitability. MarketBeat analyst coverage for Vaxart is minimal—only a single analyst currently follows the stock—which should give investors pause. The company also has just 18% institutional ownership. On the positive side, VXRT has only about 2% short interest, which may help limit some volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure and industrial sensing. The company's hardware and software solutions enable precise 3D mapping required for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on developing compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision rests on two factors: the ongoing push toward vehicle automation and potential partnerships with major automotive manufacturers. If the company can demonstrate performance or cost advantages, it could secure supply agreements or licensing deals that substantially improve revenue visibility. Microvision's technology could also be applied in robotics and smart-city infrastructure, adding optionality to its growth story. Despite the promise, Microvision faces stiff competition from LiDAR firms such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability remains uncertain, and repeated delays in commercial adoption of LiDAR continue to frustrate investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, roughly a 169% premium to its Jan. 15 closing price. Like many speculative names, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), which can lead to pronounced volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization and digital asset management. The company helps organizations convert raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain and analytics tools, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems may miss. The bullish thesis for Datavault AI rests on its niche focus and potential scalability. As data becomes an increasingly valuable commodity, businesses—and potentially individuals—are seeking ways to safely monetize digital information. Datavault's technology could benefit from broader AI adoption and growing interest in data sovereignty. Early traction or strategic partnerships could catalyze investor confidence. That said, Datavault AI operates in a highly experimental space. Its business model is still evolving, and a clear path to meaningful revenue is unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in the data-as-an-asset thesis rather than near-term earnings potential.
| 
